| All patients | ICS group | NICS group | p value |
---|---|---|---|---|
 | N = 104 | n = 51 | n = 53 |  |
Age, years | 42.5 (35.0–57.3) | 42.0 (38.0–55.0) | 44.0 (31.5–60.5) | 0.509 |
Cough duration, weeks | 9.5 ± 1.3 | 9.6 ± 1.4 | 9.4 ± 1.2 | 0.458 |
Sex | Â | Â | Â | 0.649 |
 Male | 39 (37.5%) | 18 (35.3%) | 21 (39.6%) |  |
 Female | 65 (62.5%) | 33 (64.7%) | 32 (60.4%) |  |
Smoking history | ||||
 Former smoker | 5 (4.8%) | 3 (5.9%) | 2 (3.8%) | 0.965 |
 Current smoker | 3 (2.9%) | 1 (2.0%) | 2 (3.8%) | 1.000 |
 Never smoked | 96 (92.3%) | 47 (92.2%) | 49 (92.4%) | 1.000 |
Comorbidity | ||||
 Hypertension | 17 (16.3%) | 6 (11.8%) | 11 (20.8%) | 0.215 |
 Diabetes | 3 (2.9%) | 1 (2.0%) | 2 (3.8%) | 1.000 |
 Cardiovascular and cerebrovascular diseases | 3 (2.9%) | 0 (0.0%) | 3 (5.7%) | 0.255 |
Symptoms | ||||
 Dry cough | 43 (41.3%) | 19 (37.3%) | 24 (45.3%) | 0.406 |
 Sputum | 61 (58.7%) | 32 (62.7%) | 29 (54.7%) | 0.406 |
 Dyspnea | 50 (48.1%) | 28 (54.9%) | 22 (41.5%) | 0.172 |
 Wheeze | 17 (18.3%) | 10 (19.6%) | 7 (13.2%) | 0.378 |
 Insomnia | 4 (3.8%) | 1 (2.0%) | 3 (5.7%) | 0.638 |
 Fatigue | 10 (9.6%) | 6 (11.8%) | 4 (7.5%) | 0.692 |
 Dizziness and headache | 5 (4.8%) | 3 (5.9%) | 2 (3.8%) | 0.965 |
 Chest pain | 5 (4.8%) | 3 (5.9%) | 2 (3.8%) | 0.965 |
CET | 11.0 (9.0–15.0) | 12.0 (9.0–16.0) | 10.0 (9.0–13.0) | 0.142 |
Dyspnea mMRC | ||||
 0 | 54 (51.9%) | 23 (45.1%) | 31 (58.5%) | 0.172 |
 1  2 | 27 (26.0%) 14 (13.5%) | 15 (29.4%) 7 (13.7%) | 12 (22.6%) 7 (13.2%) | 0.431 0.938 |
 3 | 9 (8.7%) | 6 (11.8%) | 3 (5.7%) | 0.448 |